以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月26日南向资金减持22.35万股一脉阳光（02522.HK）。近5个交易日中，获南向资金 减持的有4天，累计净减持106.95万股。近20个交易日中，获南向资金增持的有11天，累计净增持357.8 万股。截至目前，南向资金持有一脉阳光（02522.HK）1.42亿股，占公司已发行普通股的48.24%。 江西一脉阳光集团股份有限公司是一家主要从事医学影像专科医疗业务的中国公司。该公司主要提供医 学影像服务及解决方案。该公司经营三个分部。影像中心服务通过旗舰型影像中心为患者及其他医疗保 健消费者提供影像检查及诊断服务。影像解决方案服务主要帮助医院等医疗机构客户选择及采购满足他 们发展需要的合适影像设备，以及提供一系列配套模块化解决方案。一脉云服务为影像中心服务业务发 展、信息化管理及数据驱动运营提供支撑。 ...

Group 1 - The core point of the article highlights the recent trading activity of the company Yipai Sunshine (02522.HK), indicating a decrease in holdings by southbound funds on February 12, with a reduction of 329,000 shares, representing a change of -0.23% [1][2] - Over the past five trading days, there were three days of net increases in holdings by southbound funds, totaling an increase of 618,000 shares [1] - In the last twenty trading days, there were thirteen days of net increases, with a cumulative net increase of 8.544 million shares, indicating a generally positive trend in investor interest [1] Group 2 - As of now, southbound funds hold 14.3 million shares of Yipai Sunshine, which accounts for 48.5% of the company's total issued ordinary shares [1] - Yipai Sunshine Group Co., Ltd. primarily engages in specialized medical imaging services in China, providing imaging services and solutions [2] - The company operates three segments: imaging center services, imaging solutions, and Yipai cloud services, supporting the development of imaging center services and data-driven operations [2]

Core Insights - Southbound funds increased their holdings in Yimai Sunshine (02522.HK) by 419,500 shares on February 6, with a total net increase of 1,311,000 shares over the last five trading days [1] - Over the past 20 trading days, Yimai Sunshine has seen a net increase of 9,381,500 shares from southbound funds, with 13 days of net buying [1] - Currently, southbound funds hold 142 million shares of Yimai Sunshine, accounting for 48.43% of the company's total issued ordinary shares [1] Company Overview - Jiangxi Yimai Sunshine Group Co., Ltd. is primarily engaged in specialized medical imaging services in China [1] - The company offers medical imaging services and solutions through three main divisions: imaging center services, imaging solutions, and Yimai cloud services [1] - Imaging center services provide diagnostic imaging examinations to patients and healthcare consumers through flagship imaging centers [1] - Imaging solutions assist hospitals and medical institutions in selecting and procuring appropriate imaging equipment, along with providing modular solutions [1] - Yimai cloud services support the development of imaging center services, information management, and data-driven operations [1]

一脉阳光集团（02522.HK）作为国内医学影像服务领域的领先企业，近年来持续深化"医学影像数据+AI基座模型+影像中心场景"三位一体战略布局。为系 统推进AI技术与影像业务的深度融合，集团于2020年战略孵化并持续投资成立上海影禾医脉智能科技有限公司，将其打造为集团AI技术研发与应用落地的 核心载体，形成紧密的"孵化孪生"与业务协同关系。一脉阳光通过整合自身覆盖全国的百余家影像中心网络、海量标准化影像数据资源，与影禾医脉的AI技 术研发能力相结合，共同构建了从数据、模型到场景应用的全闭环AI生态体系。 AI产品/服务体系 核心亮点 1. 构筑"数据-大模型-应用"完整AI产业闭环 一脉阳光作为行业领先的影像医疗服务集团，依托全国性影像中心网络，构建了高质量标准化的医学影像数据资源池。旗下百余家影像中心每日产生数万例 标准化影像数据，历史累计沉淀超 4000 万例高质量影像资产，成为 AI 研发的核心战略基础。 通过与影禾医脉AI研发实力的深度协同，这一规模化数据支持影禾医脉训练迭代出了全球首个跨模态全流程 "影禾觅芽" 医学影像基座大模型。该模型能力 反哺赋能一脉阳光影像中心后，有效提升诊断效率与一致性，同 ...

Core Viewpoint - Southbound funds increased their holdings in Yipai Sunshine (02522.HK) by 1.2575 million shares on December 17, indicating a positive sentiment towards the company [1] Group 1: Southbound Fund Activity - Over the past 5 trading days, there were 3 days of net reductions in southbound fund holdings, totaling a net decrease of 213,500 shares [1] - In the last 20 trading days, there were 14 days of net increases in southbound fund holdings, with a cumulative net increase of 8.93 million shares [1] - Currently, southbound funds hold 135 million shares of Yipai Sunshine, accounting for 45.98% of the company's total issued ordinary shares [1] Group 2: Company Overview - Jiangxi Yipai Sunshine Group Co., Ltd. primarily engages in specialized medical imaging services in China [1] - The company offers medical imaging services and solutions, operating through three divisions [1] - The Imaging Center Services provide imaging examinations and diagnostic services to patients and healthcare consumers [1] - The Imaging Solutions Services assist hospitals and medical institutions in selecting and procuring suitable imaging equipment, along with providing a range of modular solutions [1] - Yipai Cloud Services support the development of imaging center services, information management, and data-driven operations [1]

Group 1 - The core point of the article is that southbound funds have increased their holdings in Yipai Sunshine (02522.HK), with a total net increase of 443.35 million shares over the last five trading days [1][2] - As of November 21, 2025, southbound funds hold 130 million shares of Yipai Sunshine, accounting for 44.32% of the company's total issued ordinary shares [1][2] - The increase in holdings has been observed on three out of the last five trading days, indicating a positive trend in investor sentiment towards the company [1][2] Group 2 - Yipai Sunshine Group Co., Ltd. is primarily engaged in specialized medical imaging services in China, providing imaging services and solutions [2] - The company operates three segments: imaging center services, imaging solutions, and Yipai cloud services, which support the development of imaging center services and data-driven operations [2]

Core Viewpoint - The company, Yimai Sunshine (02522), has seen a stock price increase of over 6% during trading, currently up 4.18% at HKD 17.95, with a trading volume of HKD 178 million. This is attributed to the recent signing of a capital increase subscription agreement with Shanghai Yinghe Medical Technology Co., Ltd. [1] Group 1: Company Developments - The company has entered into a capital increase agreement to subscribe to nearly RMB 100 million of new registered capital in Yinghe Medical Technology, which will enhance its equity stake in the company [1]. - This capital increase is a significant step in the company's strategy to implement a three-pronged approach in medical imaging AI, which includes medical imaging data, AI foundational models, and imaging center scenarios [1]. Group 2: Industry Position - Yimai Sunshine is recognized as a leading third-party medical imaging service platform in China, with a synergistic business model across imaging center services, imaging solutions, and Yimai Cloud [1]. - The company has developed a large-scale network of imaging centers, accumulating a high-quality medical imaging database covering over 200 disease types and more than 10 million cases, with a daily addition of 20,000 to 30,000 structured data entries [1]. - The company has successfully completed the full process exploration of "data resources - data assets - data transactions," with multiple imaging data products listed and traded on data exchanges [1].

Group 1 - Lumexa Imaging submitted an IPO filing to the SEC on November 17, seeking to list on NASDAQ under the ticker symbol LMRI, with a secret application filed on June 12, 2025 [1] - Lumexa Imaging provides medical imaging services through outpatient centers, offering radiology exams and diagnostic imaging services, including MRI, CT, PET scans, X-rays, and ultrasound, with 184 outpatient centers across the U.S. [4] - For the nine months ending September 30, 2025, Lumexa Imaging reported revenues of $566 million, up from $534 million in the same period last year, with net losses of $18.41 million compared to $69.04 million [4] Group 2 - York Space Systems filed an IPO with the SEC on the same day, aiming to list on the NYSE under the ticker symbol YSS, with a secret application submitted on September 29, 2025 [1] - York Space Systems specializes in the design, manufacturing, and mission execution of small to medium-sized satellites for space and defense projects, producing satellite and critical mission systems [6] - The company reported revenues of $357 million for the twelve months ending September 30, 2025 [6] Group 3 - Four SPACs, Aperture AC, ITHAX Acquisition III, Praetorian Acquisition, and Breeze Acquisition II, also submitted IPO filings, all seeking to list on NASDAQ [1] - Aperture AC focuses on digital assets, targeting the mid-to-low end market, including tokenized asset infrastructure and decentralized finance [7] - ITHAX Acquisition III targets sectors such as asset management, hospitality, dining, tourism, and entertainment, while Praetorian Acquisition aims to acquire traditional industries undergoing transformation through automation and AI [7] - Breeze Acquisition II is focused on global healthcare, biotechnology, advanced manufacturing, robotics, and AI, with respective fundraising goals of $90 million, $200 million, $220 million, and $125 million [7]

Core Viewpoint - The company is positioned as a leader in China's third-party medical imaging industry, with significant growth potential driven by AI and data asset management, leading to a "buy" rating with a target price of 30.4 HKD for 2026 [1][2]. Financial Projections - Expected revenue for the company from 2025 to 2027 is projected at 1.05 billion, 1.39 billion, and 1.68 billion RMB, reflecting year-on-year growth rates of 38.1%, 32.2%, and 21.2% respectively [1]. - Net profit is forecasted to be 25 million, 60 million, and 105 million RMB for the same years, with significant growth rates of 137.7% and 76.5% in 2026 and 2027 [1]. - EBITDA is anticipated to reach 236 million, 282 million, and 341 million RMB, with year-on-year growth of 43.0%, 19.5%, and 20.9% [1]. Business Model and Operations - The company operates a leading third-party medical imaging service platform in China, with a focus on imaging center services, imaging solutions, and the "Yimai Cloud" platform, achieving a revenue of 467 million RMB in the first half of 2025, a 12.9% increase year-on-year [2]. - Imaging solutions revenue reached 161 million RMB, showing an impressive growth of 88.9%, and accounting for 34.5% of total revenue [2]. - The company has established a nationwide network of imaging centers, with 115 centers operational across 17 provinces, creating multiple barriers to entry through equipment, licenses, and brand resources [3]. Data Asset Management and AI Integration - The company has built a high-quality medical imaging database covering over 200 diseases, with daily additions of 20,000 to 30,000 structured data entries, facilitating the exploration of data asset management and commercialization [4]. - The company has launched a full-modal AI-assisted diagnostic product, achieving leading results in image understanding and report generation, and has developed a closed-loop ecosystem for data-driven model iteration and service feedback [4].

Group 1 - The core point of the news is that southbound funds have reduced their holdings in Yipai Sunshine (02522.HK) by 436,000 shares on November 17, 2025, marking a cumulative net reduction of 1,467,500 shares over the last five trading days [1] - Over the past 20 trading days, there have been 11 days of net reductions in holdings by southbound funds, totaling 1,294,000 shares [1] - As of now, southbound funds hold 125 million shares of Yipai Sunshine, which accounts for 42.66% of the company's total issued ordinary shares [1] Group 2 - On November 17, 2025, the total number of shares held was 125 million, with a decrease of 436,000 shares, reflecting a change of -0.35% [2] - The trading history shows fluctuations in holdings, including an increase of 184,500 shares on November 14, 2025, and a decrease of 949,000 shares on November 12, 2025 [2] - Yipai Sunshine Group Co., Ltd. primarily engages in specialized medical imaging services, providing imaging examination and diagnostic services through flagship imaging centers, and offering solutions for hospitals to select and procure imaging equipment [2]